IsoRay chief executive steps down

By staff writers

February 27, 2008 -- The chief executive of medical isotope developer IsoRay of Richland, WA, has left the company.

IsoRay said that Roger Girard has left the firm for personal reasons. Girard had been chairman and CEO of IsoRay since July 2005.

Replacing Girard as chairman and interim CEO is Dwight Babcock, who has been a member of the company's board of directors. The company also announced that board member Robert Kauffman has accepted a position as vice chairman, and vice president of marketing Lori Woods will be acting chief operating officer.

IsoRay takes stake in Russian manufacturer, January 23, 2008

IsoRay's cesium isotope used for eye cancer, December 13, 2007

IsoRay posts Q1 2008 results, November 9, 2007

IsoRay inks global alliance with Belgian firm, September 27, 2007

IsoRay expands new brachytherapy plant, August 30, 2007

Copyright © 2008


To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking